Evidence map›Paper›PMID 29311813›Full record

ArticleFrontiers in molecular neuroscience2017

IL-33 Provides Neuroprotection through Suppressing Apoptotic, Autophagic and NF-κB-Mediated Inflammatory Pathways in a Rat Model of Recurrent Neonatal Seizure.

Yuan Gao, Cheng-Liang Luo, Li-Li Li, Guang-Hua Ye, Cheng Gao, Hao-Chen Wang, Wen-Wen Huang, Tao Wang, Zu-Feng Wang, Hong Ni and 2 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in molecular neuroscience, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed, 1 pooled it
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 1 synthesis or guideline pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Targeting IL-33 in Precision Neuroimmunology: Cellular Mechanisms and Therapeutic Strategies for CNS Disorders.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2026
    Review
  4. Article
  5. Interleukins in Epilepsy: Friend or Foe.Neuroscience bulletin · 2024
    Review
  6. Zinc finger protein 263 upregulates interleukin 33 and suppresses autophagy to accelerate the malignant progression of non-small cell lung cancer.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2024
    Article
  7. Article
  8. Review
  9. The Role of the Interleukin-1 Family in Complications of Prematurity.International journal of molecular sciences · 2023
    Review
  10. Article
  11. Review
  12. KIF2A decreases IL-33 production and attenuates allergic asthmatic inflammation.Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology · 2022
    Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Different intensity of autophagy regulate interleukin-33 to control the uncontrolled inflammation of acute lung injury.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2019
    Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Yuan GaoDepartment of Forensic Medicine, Wenzhou Medical University, Wenzhou, China.
Cheng-Liang LuoDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Li-Li LiDepartment of Neurology Laboratory, Children's Hospital of Soochow University, Suzhou, China.
Guang-Hua YeDepartment of Forensic Medicine, Wenzhou Medical University, Wenzhou, China.
Cheng GaoDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Hao-Chen WangDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Wen-Wen HuangDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Tao WangDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Zu-Feng WangDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Hong NiDepartment of Neurology Laboratory, Children's Hospital of Soochow University, Suzhou, China.
Xi-Ping ChenDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Lu-Yang TaoDepartment of Forensic Medicine, Medical School of Soochow University, Suzhou, China.
Soochow University · CNWenzhou Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Interleukin-33 (IL-33) is a novel identified chromatin-associated cytokine of IL-1 family cytokines. It signals through a heterodimer comprised of ST2L and IL-1RAcp, and plays a crucial role in many diseases. However, very little is known about the role and underlying intricate mechanisms of IL-33 in recurrent neonatal seizure (RNS). To determine whether IL-33 plays an important regulatory role, we established a neonatal seizure model in this study. Rats were subjected to recurrent seizures induced by inhaling volatile flurothyl. Recombinant IL-33 or PBS were also administered by intraperitoneally (IP) before surgery, respectively. Here, our current results indicated that RNS contributed to a significant reduction in IL-33 and its specific receptor (ST2L) expressions in cortex. While, in hippocampus, RNS induced an increase in IL-33 and ST2L evidently, compared with Sham group. After injection with IL-33, however, a remarkable increase in total IL-33 was detected both in brain cortex and hippocampus. In addition, IL-33 was mainly co-localized in the nuclear of GFAP

Indexed as

apoptosisautophagyIL-33recurrent neonatal seizureST2L

Identifiers

PMID29311813
PMCPMC5742123
OpenAlexW2776677752

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.